Skip to main content
Top
Published in: Journal of Neuro-Oncology 1/2017

01-10-2017 | Clinical Study

Clinical, radiological, pathological and prognostic aspects of intraventricular oligodendroglioma: comparison with central neurocytoma

Authors: Xiang Xiao, Jun Zhou, Jun Wang, Lei Yang, Chunhong Wang, Yikai Xu, Yuankui Wu

Published in: Journal of Neuro-Oncology | Issue 1/2017

Login to get access

Abstract

Studies comparing intraventricular oligodendroglioma (IVO) and central neurocytoma (CN) in terms of their clinical, radiological and pathological features are scarce. We, therefore, investigated the similarities and differences between these types of tumors to get a better understanding of how they may be more properly diagnosed and treated. The clinical manifestations, CT/MRI findings, pathological characteristics and clinical outcomes of 8 cases of IVOs and 12 cases of CNs were analyzed retrospectively. Both IVO and CN occurred most commonly in young adults and manifested with symptoms of increased intracranial pressure secondary to obstructive hydrocephalus. However, they were radiologically different in location (p = 0.007), diffusion-weighted imaging (p = 0.001), “scalloping” appearance (p = 0.006), flow void sign (p = 0.006) and ventricular wall invasion (p = 0.000). Histologically, significant differences in mitotic count (p = 0.008) and parenchymal infiltration (p = 0.01) were noted. Immunohistochemically, significant differences in the expression of Olig2 (p = 0.000), Syn (p = 0.01) and NeuN (p = 0.000) were observed. In addition, MIB-1 labeling index (p = 0.035) and case fatality rate (p = 0.021) of IVO were much higher than those of CN, while survival rate of IVO was much lower than that of CN (p = 0.028). IVO and CN are similar in onset age and clinical manifestations, but have different imaging and pathological features. Patients with IVOs may have a relatively poorer prognosis compared to those with CNs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820CrossRefPubMed Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820CrossRefPubMed
2.
go back to reference Maiuri F, Giamundo A, Di Prisco B (1982) Primary intraventricular oligodendroglioma. Surg Neurol 18:364–366CrossRefPubMed Maiuri F, Giamundo A, Di Prisco B (1982) Primary intraventricular oligodendroglioma. Surg Neurol 18:364–366CrossRefPubMed
3.
go back to reference Dolinskas CA, Simeone FA (1987) CT characteristics of intraventricular oligodendrogliomas. Am J Neuroradiol 8:1077–1082PubMed Dolinskas CA, Simeone FA (1987) CT characteristics of intraventricular oligodendrogliomas. Am J Neuroradiol 8:1077–1082PubMed
4.
go back to reference Dickson W (1926) Oligodendroglioma of the 3rd ventricle. Brain 49:578–580CrossRef Dickson W (1926) Oligodendroglioma of the 3rd ventricle. Brain 49:578–580CrossRef
5.
go back to reference Hassoun J, Gambarelli D, Grisoli F, Pellet W, Salamon G et al (1982) Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathologica 56:151–156CrossRefPubMed Hassoun J, Gambarelli D, Grisoli F, Pellet W, Salamon G et al (1982) Central neurocytoma. An electron-microscopic study of two cases. Acta Neuropathologica 56:151–156CrossRefPubMed
6.
go back to reference Choudhari KA, Kaliaperumal C, Jain A, Sarkar C, Soo M et al (2009) Central neurocytoma: a multi-disciplinary review. B J Neurosurg 23:585–595CrossRef Choudhari KA, Kaliaperumal C, Jain A, Sarkar C, Soo M et al (2009) Central neurocytoma: a multi-disciplinary review. B J Neurosurg 23:585–595CrossRef
7.
go back to reference Schmidt MH, Gottfried ON, von Koch CS, Chang SM, McDermott MW (2004) Central neurocytoma: a review. J Neurooncol 66:377–384CrossRefPubMed Schmidt MH, Gottfried ON, von Koch CS, Chang SM, McDermott MW (2004) Central neurocytoma: a review. J Neurooncol 66:377–384CrossRefPubMed
8.
go back to reference Sharma MC, Deb P, Sharma S, Sarkar C (2006) Neurocytoma: a comprehensive review. Neurosurg Rev 29:270–285CrossRefPubMed Sharma MC, Deb P, Sharma S, Sarkar C (2006) Neurocytoma: a comprehensive review. Neurosurg Rev 29:270–285CrossRefPubMed
9.
go back to reference Hasuo K, Fukui M, Tamura S, Yasumori K, Uchino A et al (1987) Oligodendrogliomas of the lateral ventricle: computed tomography and angiography. J Comput Tomogr 11:376–382CrossRefPubMed Hasuo K, Fukui M, Tamura S, Yasumori K, Uchino A et al (1987) Oligodendrogliomas of the lateral ventricle: computed tomography and angiography. J Comput Tomogr 11:376–382CrossRefPubMed
10.
go back to reference Lee KS, Kelly DJ (1990) Primary oligodendroglioma of the lateral ventricle. South Med J 83:254–255CrossRefPubMed Lee KS, Kelly DJ (1990) Primary oligodendroglioma of the lateral ventricle. South Med J 83:254–255CrossRefPubMed
11.
go back to reference Yuen ST, Fung CF, Ng TH, Leung SY (1992) Central neurocytoma: its differentiation from intraventricular oligodendroglioma. Child Nerv Syst 8:383–388CrossRef Yuen ST, Fung CF, Ng TH, Leung SY (1992) Central neurocytoma: its differentiation from intraventricular oligodendroglioma. Child Nerv Syst 8:383–388CrossRef
12.
go back to reference Atalay B, Altinors N, Caner H, Bavbek M, Cekinmez M, Hasturk A (2002) Primary biventricular oligodendroglioma. Turk Neurosurg 12:138–139 Atalay B, Altinors N, Caner H, Bavbek M, Cekinmez M, Hasturk A (2002) Primary biventricular oligodendroglioma. Turk Neurosurg 12:138–139
13.
go back to reference Natale M, Spennato P, Savarese L, Bocchetti A, Esposito S, Barbato R (2005) Anaplastic oligodendroglioma presenting with drop metastases in the cauda equina. Clin Neurol Neurosurg 107:417–420CrossRefPubMed Natale M, Spennato P, Savarese L, Bocchetti A, Esposito S, Barbato R (2005) Anaplastic oligodendroglioma presenting with drop metastases in the cauda equina. Clin Neurol Neurosurg 107:417–420CrossRefPubMed
14.
go back to reference Zada G, McNatt SA, Gonzalez-Gomez I, McComb JG (2009) Anaplastic intraventricular oligodendroglioma: case report and review of the literature. Surg Neurol 71:693–700CrossRefPubMed Zada G, McNatt SA, Gonzalez-Gomez I, McComb JG (2009) Anaplastic intraventricular oligodendroglioma: case report and review of the literature. Surg Neurol 71:693–700CrossRefPubMed
15.
go back to reference Matsumoto H, Yoshida Y (2015) Primary intraventricular oligodendroglioma: a case report of the usefulness of Olig2 immunohistochemistry for diagnosis. Neuropathology 35:553–560CrossRefPubMed Matsumoto H, Yoshida Y (2015) Primary intraventricular oligodendroglioma: a case report of the usefulness of Olig2 immunohistochemistry for diagnosis. Neuropathology 35:553–560CrossRefPubMed
16.
go back to reference Pomero E, La Piana R, Cortes MDP, Tampieri D (2012) Intraventricular Localization of an anaplastic oligodedendroglioma: a rare event. Can J Neurol Sci 39:649–651CrossRefPubMed Pomero E, La Piana R, Cortes MDP, Tampieri D (2012) Intraventricular Localization of an anaplastic oligodedendroglioma: a rare event. Can J Neurol Sci 39:649–651CrossRefPubMed
17.
go back to reference Kim JW, Kim DG, Kim IK, Kim YH, Choi SH et al (2013) Central neurocytoma: long-term outcomes of multimodal treatments and management strategies based on 30 years’ experience in a single institute. Neurosurgery 72:407–413CrossRefPubMed Kim JW, Kim DG, Kim IK, Kim YH, Choi SH et al (2013) Central neurocytoma: long-term outcomes of multimodal treatments and management strategies based on 30 years’ experience in a single institute. Neurosurgery 72:407–413CrossRefPubMed
18.
go back to reference von Deimling A, Janzer R, Kleihues P, Wiestler OD (1990) Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies. Acta Neuropathol 79:473–479CrossRef von Deimling A, Janzer R, Kleihues P, Wiestler OD (1990) Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies. Acta Neuropathol 79:473–479CrossRef
19.
go back to reference Kendall B, Reider-Grosswasser I, Valentine A (1983) Diagnosis of masses presenting within the ventricles on computed tomography. Neuroradiology 25:11–22CrossRefPubMed Kendall B, Reider-Grosswasser I, Valentine A (1983) Diagnosis of masses presenting within the ventricles on computed tomography. Neuroradiology 25:11–22CrossRefPubMed
20.
go back to reference Bradac GB, Ferszt R, Bender A, Schorner W (1986) Peritumoral edema in meningiomas. A radiological and histological study. Neuroradiology 28:304–312CrossRefPubMed Bradac GB, Ferszt R, Bender A, Schorner W (1986) Peritumoral edema in meningiomas. A radiological and histological study. Neuroradiology 28:304–312CrossRefPubMed
21.
go back to reference Schmid UD, Seiler RW (1986) Management of obstructive hydrocephalus secondary to posterior fossa tumors by steroids and subcutaneous ventricular catheter reservoir. J Neurosurg 65:649–653CrossRefPubMed Schmid UD, Seiler RW (1986) Management of obstructive hydrocephalus secondary to posterior fossa tumors by steroids and subcutaneous ventricular catheter reservoir. J Neurosurg 65:649–653CrossRefPubMed
22.
go back to reference Chen CL, Shen CC, Wang J, Lu CH, Lee HT (2008) Central neurocytoma: a clinical, radiological and pathological study of nine cases. Clin Neurol Neurosurg 110:129–136CrossRefPubMed Chen CL, Shen CC, Wang J, Lu CH, Lee HT (2008) Central neurocytoma: a clinical, radiological and pathological study of nine cases. Clin Neurol Neurosurg 110:129–136CrossRefPubMed
23.
go back to reference Yang I, Ung N, Chung LK, Nagasawa DT, Thill K et al (2015) Clinical manifestations of central neurocytoma. Neurosurg Clin N Am 26:5–10CrossRefPubMed Yang I, Ung N, Chung LK, Nagasawa DT, Thill K et al (2015) Clinical manifestations of central neurocytoma. Neurosurg Clin N Am 26:5–10CrossRefPubMed
24.
go back to reference Patel DM, Schmidt RF, Liu JK (2013) Update on the diagnosis, pathogenesis, and treatment strategies for central neurocytoma. J Clin Neurosci 20:1193–1199CrossRefPubMed Patel DM, Schmidt RF, Liu JK (2013) Update on the diagnosis, pathogenesis, and treatment strategies for central neurocytoma. J Clin Neurosci 20:1193–1199CrossRefPubMed
25.
go back to reference Jaiswal S, Vij M, Rajput D, Mehrotra A, Jaiswal AK et al (2011) A clinicopathological, immunohistochemical and neuroradiological study of eight patients with central neurocytoma. J Clin Neurosci 18:334–339CrossRefPubMed Jaiswal S, Vij M, Rajput D, Mehrotra A, Jaiswal AK et al (2011) A clinicopathological, immunohistochemical and neuroradiological study of eight patients with central neurocytoma. J Clin Neurosci 18:334–339CrossRefPubMed
26.
27.
go back to reference Niiro T, Tokimura H, Hanaya R, Hirano H, Fukukura Y et al (2012) MRI findings in patients with central neurocytomas with special reference to differential diagnosis from other ventricular tumours near the foramen of Monro. J Clin Neurosci 19:681–686CrossRefPubMed Niiro T, Tokimura H, Hanaya R, Hirano H, Fukukura Y et al (2012) MRI findings in patients with central neurocytomas with special reference to differential diagnosis from other ventricular tumours near the foramen of Monro. J Clin Neurosci 19:681–686CrossRefPubMed
28.
go back to reference Zhang B, Luo BN, Zhang ZW, Sun GX, Wen JM (2004) Central neurocytoma: a clinicopathological and neuroradiological study. Neuroradiology 46:888–895CrossRefPubMed Zhang B, Luo BN, Zhang ZW, Sun GX, Wen JM (2004) Central neurocytoma: a clinicopathological and neuroradiological study. Neuroradiology 46:888–895CrossRefPubMed
29.
go back to reference Tlili-Graiess K, Mama N, Arifa N, Kadri K, Hasni I et al (2014) Diffusion weighted MR imaging and proton MR spectroscopy findings of central neurocytoma with pathological correlation. J Neuroradiol 41:243–350CrossRefPubMed Tlili-Graiess K, Mama N, Arifa N, Kadri K, Hasni I et al (2014) Diffusion weighted MR imaging and proton MR spectroscopy findings of central neurocytoma with pathological correlation. J Neuroradiol 41:243–350CrossRefPubMed
30.
go back to reference Engelhard HH, Stelea A, Cochran EJ (2002) Oligodendroglioma: pathology and molecular biology. Surg Neurol 58:111–117CrossRefPubMed Engelhard HH, Stelea A, Cochran EJ (2002) Oligodendroglioma: pathology and molecular biology. Surg Neurol 58:111–117CrossRefPubMed
31.
go back to reference Sharma MC, Sarkar C, Karak AK, Gaikwad S, Mahapatra AK, Mehta VS (1999) Intraventricular neurocytoma: a clinicopathological study of 20 cases with review of the literature. J Clin Neurosci 6:319–323CrossRefPubMed Sharma MC, Sarkar C, Karak AK, Gaikwad S, Mahapatra AK, Mehta VS (1999) Intraventricular neurocytoma: a clinicopathological study of 20 cases with review of the literature. J Clin Neurosci 6:319–323CrossRefPubMed
32.
go back to reference Marie Y, Sanson M, Mokhtari K, Leuraud P, Kujas M et al (2001) Olig2 as a specific marker of oligodendroglialtumour cells. Lancet 358:298–300CrossRefPubMed Marie Y, Sanson M, Mokhtari K, Leuraud P, Kujas M et al (2001) Olig2 as a specific marker of oligodendroglialtumour cells. Lancet 358:298–300CrossRefPubMed
33.
go back to reference Yokoo HYMG, Nobusawa S, Takebayashi H, Ikenaka K, Isoda K et al (2004) Anti-human olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas. Am J Pathol 164:1717–1725CrossRefPubMedPubMedCentral Yokoo HYMG, Nobusawa S, Takebayashi H, Ikenaka K, Isoda K et al (2004) Anti-human olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas. Am J Pathol 164:1717–1725CrossRefPubMedPubMedCentral
34.
go back to reference Hassoun J, Soylemezoglu F, Gambarelli D, Figarella-Branger D, von Ammon K, Kleihues P (1993) Central neurocytoma: a synopsis of clinical and histological features. Brain Pathol 3:297–306CrossRefPubMed Hassoun J, Soylemezoglu F, Gambarelli D, Figarella-Branger D, von Ammon K, Kleihues P (1993) Central neurocytoma: a synopsis of clinical and histological features. Brain Pathol 3:297–306CrossRefPubMed
35.
go back to reference Soylemezoglu F, Onder S, Tezel GG, Berker M (2003) Neuronal nuclear antigen (NeuN): a new tool in the diagnosis of central neurocytoma. Pathol Res Pract 199:463–468CrossRefPubMed Soylemezoglu F, Onder S, Tezel GG, Berker M (2003) Neuronal nuclear antigen (NeuN): a new tool in the diagnosis of central neurocytoma. Pathol Res Pract 199:463–468CrossRefPubMed
36.
go back to reference Preusser M, Laggner U, Haberler C, Heinzl H, Budka H, Hainfellner JA (2006) Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology. Histopathology 48:438–444CrossRefPubMed Preusser M, Laggner U, Haberler C, Heinzl H, Budka H, Hainfellner JA (2006) Comparative analysis of NeuN immunoreactivity in primary brain tumours: conclusions for rational use in diagnostic histopathology. Histopathology 48:438–444CrossRefPubMed
37.
go back to reference Ishiuchi S, Tamura M (1997) Central neurocytoma: an immunohistochemical, ultrastructural and cell culture study. Acta Neuropathol 94:425–435CrossRefPubMed Ishiuchi S, Tamura M (1997) Central neurocytoma: an immunohistochemical, ultrastructural and cell culture study. Acta Neuropathol 94:425–435CrossRefPubMed
38.
go back to reference Tsuchida T, Matsumoto M, Shirayama Y, Imahori T, Kasai H, Kawamoto K (1996) Neuronal and glial characteristics of central neurocytoma: electron microscopical analysis of two cases. Acta Neuropathol 91:573–577CrossRefPubMed Tsuchida T, Matsumoto M, Shirayama Y, Imahori T, Kasai H, Kawamoto K (1996) Neuronal and glial characteristics of central neurocytoma: electron microscopical analysis of two cases. Acta Neuropathol 91:573–577CrossRefPubMed
39.
go back to reference Elek G, Slowik F, Eross L, Toth S, Szabo Z, Balint K (1999) Central neurocytoma with malignant course. Neuronal and glial differentiation and craniospinal dissemination. Pathol Oncol Res 5:155–159CrossRefPubMed Elek G, Slowik F, Eross L, Toth S, Szabo Z, Balint K (1999) Central neurocytoma with malignant course. Neuronal and glial differentiation and craniospinal dissemination. Pathol Oncol Res 5:155–159CrossRefPubMed
40.
go back to reference Brandes AA, Amista P, Gardiman M, Volpin L, Danieli D et al (2000) Chemotherapy in patients with recurrent and progressive central neurocytoma. Cancer 88:169–174CrossRefPubMed Brandes AA, Amista P, Gardiman M, Volpin L, Danieli D et al (2000) Chemotherapy in patients with recurrent and progressive central neurocytoma. Cancer 88:169–174CrossRefPubMed
41.
go back to reference Vasiljevic A, Francois P, Loundou A, Fevre-Montange M, Jouvet A et al (2012) Prognostic factors in central neurocytomas: a multicenter study of 71 cases. Am J Surg Pathol 36:220–227CrossRefPubMed Vasiljevic A, Francois P, Loundou A, Fevre-Montange M, Jouvet A et al (2012) Prognostic factors in central neurocytomas: a multicenter study of 71 cases. Am J Surg Pathol 36:220–227CrossRefPubMed
42.
43.
go back to reference Imber BS, Braunstein SE, Wu FY, Nabavizadeh N, Boehling N et al (2016) Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience. J Neurooncol 126:193–200CrossRefPubMedPubMedCentral Imber BS, Braunstein SE, Wu FY, Nabavizadeh N, Boehling N et al (2016) Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience. J Neurooncol 126:193–200CrossRefPubMedPubMedCentral
44.
go back to reference Mackenzie IR (1999) Central neurocytoma: histologic atypia, proliferation potential, and clinical outcome. Cancer 85:1606–1610CrossRefPubMed Mackenzie IR (1999) Central neurocytoma: histologic atypia, proliferation potential, and clinical outcome. Cancer 85:1606–1610CrossRefPubMed
45.
go back to reference Rades D, Schild SE (2006) Treatment recommendations for the various subgroups of neurocytomas. J Neurooncol 77:305–309CrossRefPubMed Rades D, Schild SE (2006) Treatment recommendations for the various subgroups of neurocytomas. J Neurooncol 77:305–309CrossRefPubMed
46.
go back to reference Rades D, Schild SE, Fehlauer F (2004) Prognostic value of the MIB-1 labeling index for central neurocytomas. Neurology 62:987–989CrossRefPubMed Rades D, Schild SE, Fehlauer F (2004) Prognostic value of the MIB-1 labeling index for central neurocytomas. Neurology 62:987–989CrossRefPubMed
Metadata
Title
Clinical, radiological, pathological and prognostic aspects of intraventricular oligodendroglioma: comparison with central neurocytoma
Authors
Xiang Xiao
Jun Zhou
Jun Wang
Lei Yang
Chunhong Wang
Yikai Xu
Yuankui Wu
Publication date
01-10-2017
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 1/2017
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-017-2490-0

Other articles of this Issue 1/2017

Journal of Neuro-Oncology 1/2017 Go to the issue